April 1, 2019

iBio Announces Appointment of Thomas F. Isett to Board of Directors

Accomplished Life Science Executive with Deep Bioprocess Experience NEW YORK, April 01, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO), a biologics contract manufacturer and product developer with proprietary, “green” technologies for ...

Continue Reading

October 2, 2018

iBio and CC-Pharming Hold First Design and Strategy Meeting

Texas Meeting Initiates Plan to Bring Economical, Plant-Derived Rituximab to China Market NEW YORK, Oct. 02, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced the beginning of a four-day design and strategic planning meeting with ...

Continue Reading

July 9, 2018

iBio Establishes Strategic Commercial Relationship with CC-Pharming Ltd. of Beijing, China

NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced the commencement of a strategic commercial relationship with CC-Pharming Ltd. of Beijing, China for joint development of products and manufacturing facilities for ...

Continue Reading
1 2